Health Products

RegenArouse (Lot Number 130100) and RegenErect (all lots)

· Published by Health Canada · Official notice

Details

Alert type: Foreign Product Alert (FPA)
Category: Natural health products
Issue: Product Safety, Undeclared Substance
Audience: General Public
Department: Health Canada
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Images

Details

These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.

Source of alert

U.S. Food and Drug Administration

Product names

  • RegenArouse (Lot Number 130100)
  • RegenErect (all lots)

Manufacturer / Place of origin

Unknown

Product description

These products are promoted for sexual enhancement.

RegenArouse (Lot Number 130100) is a pink capsule sold individually in foil packets labelled with the expiration date 12/5/2013 and a UPC code of 816860010079.

RegenErect is a blue capsule sold individually in foil packets labeled with a UPC code of 816860010055.

Reason for warning

The U.S. Food and Drug Administration informed consumers of a nationwide voluntary recall of one lot of RegenArouse (Lot Number 130100), and of all lots of RegenErect, after they were found to contain undeclared tadalafil.

Consumers seeking more information on the recall may contact Regeneca, Inc., directly at 1-800-690-6958 (Monday through Friday from 8 a.m. to 6 p.m. Pacific Time) for instructions on the return process.

Tadalafil is a prescription drug used to treat erectile dysfunction and should only be taken under the supervision of a health care practitioner.

Possible Side effects

Tadalafil should not be used by individuals taking any kind of nitrate drug (e.g. nitroglycerine) as it can cause potentially life-threatening low blood pressure. Individuals with heart problems are at increased risk of cardiovascular side-effects such as heart attack, stroke, chest pain, high blood pressure and abnormal heart beat. Other side effects include headache, facial flushing, indigestion, dizziness, abnormal vision, and hearing loss.

RegenArouse and RegenErect

The U.S. Food and Drug Administration informed consumers of a company recall of one lot of RegenArouse (Lot Number 130100), and of all lots of RegenErect, after they were found to contain undeclared tadalafil. Tadalafil is a prescription drug used to treat erectile dysfunction and should only be taken under the supervision of a health care practitioner.

What you should do

Canadians who have this product are advised not to use it, and should consult with a health care professional if they have concerns about their health related to the use of this product.

Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the product listed above in the Canadian marketplace.

Background

Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.

As of the date of this posting, no adverse reactions suspected to be associated with the use of this product have been reported in Canada.

Report a health or safety concern

  • Call toll-free at 1-866-234-2345.
  • Visit Health Canada's Web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.

Media enquiries

Health Canada
613-957-2983

Public enquiries

613-957-2991
1-866-225-0709
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime